# Medical Devices Medical device software is not regular software with a compliance layer bolted on top. It is a fundamentally different development discipline where every design input traces to a design output, eve... ## Medical Device Software Development: FDA & IEC 62304 Compliant FreedomDev builds FDA-compliant software for medical device companies — 21 CFR Part 11 validated systems, IEC 62304 lifecycle management, and SaMD applications with the documentation and audit trails regulators require. From Class I accessories to Class III implantable device software, we deliver the Design History File, traceability matrices, and verification/validation protocols your regulatory team needs for 510(k) and PMA submissions. --- ## Key Stats - **132 days**: average FDA 510(k) review time from submission to decision - **86**: FDA warning letters to device companies in FY2023 - **200+**: device recalls due to software issues in 2023 - **3 classes**: IEC 62304 software safety classification (A, B, C) - **293 days**: average De Novo classification request review time - **$31B+**: global medical device software market (2025) --- ## Frequently Asked Questions ### What is IEC 62304 and how does it affect medical device software development? IEC 62304 is the international standard that defines the software lifecycle processes required for medical device software. It applies to any software that is a medical device (SaMD) or software that is embedded in a medical device. The standard defines three safety classes based on the potential for harm: Class A means no injury or damage to health is possible, Class B means non-serious injury is possible, and Class C means death or serious injury is possible. Each class carries progressively more stringent documentation and verification requirements. Class C — which covers software in devices like infusion pumps, ventilators, and cardiac rhythm management systems — requires documented software architecture, detailed design, unit-level verification with coverage metrics, integration testing, and system testing, with bidirectional traceability from requirements through every decomposition level to test results. FDA recognizes IEC 62304 as a consensus standard, meaning conformance creates a presumption of compliance with FDA's software validation expectations. Not following IEC 62304 does not make your device illegal, but it means you must demonstrate equivalent rigor through an alternative approach — which in practice is harder to defend than simply following the recognized standard. ### How do you handle FDA 21 CFR Part 11 compliance in software systems? 21 CFR Part 11 compliance is not a feature you add to software — it is an architectural decision that must be made before the first line of code is written. The regulation applies to any electronic records and electronic signatures that are used to meet FDA predicate rule requirements. Our approach addresses every subpart of the regulation. For electronic records: we implement audit trails that are computer-generated, timestamped, and record the operator identity, the action taken, the previous value, the new value, and the reason for change. Records are protected from alteration by access controls and cryptographic integrity checks. For electronic signatures: we implement dual-component authentication (user ID plus password at minimum), ensure signatures are bound to the signed record such that they cannot be excised or transferred, and maintain signature manifestation records that include the printed name, date and time, and meaning of the signature (such as 'reviewed' or 'approved'). We validate the complete system following GAMP 5 methodology with IQ, OQ, and PQ protocols, and deliver a validation documentation package that includes the validation plan, functional and design specifications, test protocols, executed test results, and the validation summary report. ### What is SaMD and how is it regulated differently from device-embedded software? SaMD — Software as a Medical Device — is software that performs a medical function without being part of a hardware medical device. A mobile app that analyzes ECG data and provides a diagnosis is SaMD. Software embedded in a physical ECG machine is not SaMD — it is software in a medical device (SiMD). The distinction matters because SaMD has its own regulatory framework based on the IMDRF classification model, which evaluates two factors: the significance of the information the software provides (inform, drive, treat or diagnose) and the seriousness of the healthcare situation (non-serious, serious, critical). A SaMD that drives clinical management of a critical condition — such as an AI algorithm that directs radiation therapy dosing — faces the most stringent regulatory requirements, typically requiring a PMA or De Novo classification. A SaMD that informs clinical management of a non-serious condition may qualify for a lower-risk pathway. FDA's Digital Health Center of Excellence has published specific guidance on predetermined change control plans for SaMD, which allow manufacturers to define a set of anticipated software modifications that can be made without requiring a new premarket submission, provided the changes stay within the validated performance envelope. ### How much does FDA-compliant medical device software development cost? The cost depends on the device classification, the IEC 62304 safety class, and the scope of clinical data integration. For a Class I exempt device with Class A software — a simple utility or data display application with minimal safety risk — development including full IEC 62304 documentation typically ranges from $150K to $350K. For a Class II 510(k) device with Class B software — a diagnostic instrument, patient monitoring system, or clinical decision support tool — expect $400K to $1.2M including the software development, verification and validation activities, and the documentation package required for the 510(k) submission. For Class III PMA devices with Class C software — implantable device firmware, life-sustaining systems, or AI-driven therapeutic applications — development costs range from $800K to $3M+, reflecting the exhaustive unit-level verification, architectural risk analysis, and clinical validation requirements. These ranges include the regulatory documentation that generic software shops quote separately or do not quote at all. The documentation burden alone — requirements traceability, SOUP analysis, risk management, V&V protocols — typically represents 30-40% of total development effort for Class B and 40-50% for Class C software. ### How do you manage SOUP (Software of Unknown Provenance) in medical device projects? SOUP management is one of the most underestimated aspects of medical device software development. Every third-party library, framework, operating system component, and commercial toolkit your software uses is a SOUP item under IEC 62304, and each requires documented evaluation. Our SOUP management process starts with generating a complete software bill of materials — every dependency, including transitive dependencies pulled in by package managers. For each SOUP item, we document: the component name and version, its purpose in the device software, the safety class of the software items that use it, known anomalies from the component's issue tracker or CVE database, an assessment of whether those anomalies could affect device safety or performance, and the verification activities needed to confirm the component behaves correctly in your specific context. We version-lock all SOUP items — no automatic updates from package managers — and monitor each component's vulnerability disclosures and release notes. When a SOUP update is necessary (security patch, bug fix, or new feature requirement), we perform an impact assessment, update the SOUP documentation, and execute regression testing proportional to the change scope and the safety class of the affected software items. ### Can you integrate medical device software with hospital EHR systems like Epic and Cerner? Yes, and this is increasingly a market requirement rather than a nice-to-have. Hospitals running Epic, Cerner (now Oracle Health), MEDITECH, or Allscripts expect medical devices to integrate with their clinical workflows — sending device data to the patient record, receiving patient demographics and orders, and conforming to the hospital's IT security policies. The primary integration standards are HL7 FHIR (the modern REST-based standard that Epic and Cerner both support), HL7 V2 (the legacy messaging standard still running in most hospital interfaces), and DICOM (for imaging devices). We implement IHE integration profiles that hospitals use to evaluate device interoperability: PDQ (Patient Demographics Query) for patient matching, PIX (Patient Identifier Cross-Referencing) for multi-system patient identity, and device-specific profiles depending on your clinical use case. Every integration is validated with documented test protocols covering normal data exchange, error handling, network failure recovery, and edge cases like duplicate patient records or malformed messages. For FDA submission purposes, we document the interoperability architecture in the Software Architecture Document and include integration test results in the verification evidence package. --- ## FDA 21 CFR Part 11 Compliance in Software Medical device software is not regular software with a compliance layer bolted on top. It is a fundamentally different development discipline where every design input traces to a design output, every output traces to a verification activity, and every verification traces to a validation protocol — all documented in a Design History File (DHF) that FDA reviewers will scrutinize during your 510(k) or PMA submission. The average 510(k) clearance takes 132 days from submission to decision. A De Novo classification request averages 293 days. A Premarket Approval (PMA) application averages 261 days. Every one of those timelines assumes your software documentation is complete, consistent, and traceable. A single gap in your requirements traceability matrix — one design input without a corresponding verification test — and you are looking at a major deficiency letter that resets the clock. 21 CFR Part 11 defines the FDA's requirements for electronic records and electronic signatures. If your medical device software creates, modifies, maintains, archives, retrieves, or transmits any record that FDA regulations require you to keep, Part 11 applies. The requirements are specific: electronic signatures must be linked to their respective electronic records, signed records must not be altered without generating an audit trail entry, and the system must use authority checks to ensure only authorized individuals can use the system and sign records. Audit trails must be computer-generated, timestamped, and must record the operator identity, the date and time, the previous value, the new value, and the reason for the change. These are not optional features. Companies like Medtronic, Boston Scientific, and Abbott maintain validation master plans that cover every software system touching regulated data — from manufacturing execution systems to clinical data repositories to complaint handling databases. When FDA inspectors arrive for a facility inspection, 21 CFR Part 11 compliance is not a line item they check — it is a lens through which they evaluate every electronic system in your operation. The cost of getting this wrong is not hypothetical. FDA issued 86 warning letters to medical device companies in fiscal year 2023, many citing software-related deficiencies in design controls (21 CFR 820.30), quality system regulation compliance, and electronic records integrity. A 483 observation for software lifecycle documentation gaps can escalate into a warning letter, consent decree, or import alert that shuts down your ability to sell product in the United States. The recall database tells the same story: software-related recalls account for a growing percentage of Class I recalls (the most serious category, where there is reasonable probability that use of the product will cause serious adverse health consequences or death). In 2023, the FDA recalled over 200 devices due to software issues. This is not a theoretical compliance exercise. It is the difference between a product that reaches patients and one that gets pulled from the market. FreedomDev builds medical device software with these regulatory realities baked into every sprint, every code review, and every release cycle. We maintain IEC 62304 compliant software development procedures, produce the documentation artifacts your regulatory affairs team needs, and deliver validated systems that pass FDA inspection. Our development process generates the Software Requirements Specification (SRS), Software Architecture Document (SAD), Software Detailed Design Document, unit test reports, integration test reports, system test reports, and traceability matrices that map every requirement through design, implementation, and verification. We work with device companies ranging from startups filing their first 510(k) to established manufacturers like those in the Stryker and Zimmer Biomet supply chains who need validated software systems integrated into existing quality management infrastructure. --- ## Technologies - IEC 62304 - 21 CFR Part 11 - 21 CFR Part 820 - ISO 14971 Risk Management - ISO 13485 QMS - GAMP 5 - HL7 FHIR - HL7 V2 - DICOM - IEEE 11073 - ARM Cortex-M/R - RTOS (FreeRTOS, Zephyr) - Greenlight Guru - MasterControl - Polyspace - JIRA with Traceability Plugins - Git (validated repositories) - PostgreSQL - Python - C/C++ (embedded) --- **Canonical URL**: https://freedomdev.com/industries/medical-devices _Last updated: 2026-05-14_